Nurix Therapeutics, Inc. (NRIX)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch NRIX
See up to 3 months of NRIX. The 7-day demo opens the 1M and 3M ranges and puts NRIX on your watchlist.
Start 7-day demoLatest NRIX insider trades
About Nurix Therapeutics, Inc. (NRIX)
The SEC lists Nurix Therapeutics, Inc. under CIK 0001549595, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
NRIX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 12 | 49,025 | $1.17M |
| Option exercise | 26 | 98,704 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
NRIX insider transactions (Form 4)
8962 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Christine Ring - Officer | Option exercise | Common Stock | 5,786 | $8.72 | $50K | |
| Christine Ring - Officer | Open-market sale | Common Stock | 5,786 | $23.19 footnote F2 | $134K | |
| Christine Ring - Officer | Option exercise | Employee Stock Option (right to buy) | 5,786 | $0.00 | - | |
| ||||||
| Christine Ring - Officer | Option exercise | Common Stock | 5,787 | $8.72 | $50K | |
| Christine Ring - Officer | Open-market sale | Common Stock | 5,387 | $25.69 footnote F2 | $138K | |
| Christine Ring - Officer | Open-market sale | Common Stock | 400 | $26.64 footnote F3 | $11K | |
| Christine Ring - Officer | Option exercise | Employee Stock Option (right to buy) | 5,787 | $0.00 | - | |
| ||||||
| Gwenn Hansen - Officer | Option exercise | Common Stock | 1,452 | $1.86 | $3K | |
| Gwenn Hansen - Officer | Open-market sale | Common Stock | 1,452 | $25.47 | $37K | |
| Gwenn Hansen - Officer | Option exercise | Employee Stock Option (right to buy) | 1,452 | $0.00 | - | |
| Gwenn Hansen - Officer | Open-market sale | Common Stock | 1,500 | $23.87 footnote F2 | $36K | |
| Gwenn Hansen - Officer | Open-market sale | Common Stock | 2,611 | $24.64 footnote F3 | $64K | |
| ||||||
| Houte Hans van - Officer | Open-market sale | Common Stock | 1,794 | $23.89 footnote F2 | $43K | |
| Houte Hans van - Officer | Open-market sale | Common Stock | 2,967 | $24.65 footnote F3 | $73K | |
| ||||||
| Christine Ring - Officer | Option exercise | Common Stock | 5,787 | $8.72 | $50K | |
| Christine Ring - Officer | Open-market sale | Common Stock | 16,589 | $23.05 footnote F2 | $382K | |
| Christine Ring - Officer | Option exercise | Employee Stock Option (right to buy) | 5,787 | $0.00 | - | |
| ||||||
| Houte Hans van - Officer | Option exercise | Common Stock | 3,750 | $0.00 | - | |
| Houte Hans van - Officer | Option exercise | Common Stock | 2,858 | $0.00 | - | |
| Houte Hans van - Officer | Option exercise | Common Stock | 3,572 | $0.00 | - | |
| Houte Hans van - Officer | Open-market sale | Common Stock | 2,845 | $23.38 footnote F2 | $67K | |
| Houte Hans van - Officer | Option exercise | Restricted Stock Units | 3,750 | $0.00 | - | |
| Houte Hans van - Officer | Option exercise | Restricted Stock Units | 2,858 | $0.00 | - | |
| Houte Hans van - Officer | Option exercise | Restricted Stock Units | 3,572 | $0.00 | - | |
| ||||||
| Christine Ring - Officer | Option exercise | Common Stock | 3,750 | $0.00 | - | |
| Christine Ring - Officer | Option exercise | Common Stock | 2,858 | $0.00 | - | |
| Christine Ring - Officer | Option exercise | Common Stock | 3,572 | $0.00 | - | |
| Christine Ring - Officer | Open-market sale | Common Stock | 3,847 | $23.38 footnote F2 | $90K | |
| Christine Ring - Officer | Option exercise | Restricted Stock Units | 3,750 | $0.00 | - | |
| Christine Ring - Officer | Option exercise | Restricted Stock Units | 2,858 | $0.00 | - | |
| Christine Ring - Officer | Option exercise | Restricted Stock Units | 3,572 | $0.00 | - | |
| ||||||
| Gwenn Hansen - Officer | Option exercise | Common Stock | 3,750 | $0.00 | - | |
| Gwenn Hansen - Officer | Option exercise | Common Stock | 2,858 | $0.00 | - | |
| Gwenn Hansen - Officer | Option exercise | Common Stock | 3,572 | $0.00 | - | |
| Gwenn Hansen - Officer | Open-market sale | Common Stock | 3,847 | $23.38 footnote F2 | $90K | |
| Gwenn Hansen - Officer | Option exercise | Restricted Stock Units | 3,750 | $0.00 | - | |
| Gwenn Hansen - Officer | Option exercise | Restricted Stock Units | 2,858 | $0.00 | - | |
| Gwenn Hansen - Officer | Option exercise | Restricted Stock Units | 3,572 | $0.00 | - | |
| ||||||
| Christine Ring - Officer | Option exercise | Common Stock | 5,221 | $1.86 | $10K | |
| Christine Ring - Officer | Option exercise | Common Stock | 5,787 | $8.72 | $50K | |
| Christine Ring - Officer | Open-market sale | Common Stock | 11,008 | $23.56 footnote F2 | $259K | |
| Christine Ring - Officer | Option exercise | Employee Stock Option (right to buy) | 5,221 | $0.00 | - | |
| Christine Ring - Officer | Option exercise | Employee Stock Option (right to buy) | 5,787 | $0.00 | - | |
| ||||||
| Gwenn Hansen - Officer | Open-market sale | Common Stock | 5,394 | $20.00 | $108K | |
| Christine Ring - Officer | Option exercise | Common Stock | 13,333 | $7.26 | $97K | |
| Christine Ring - Officer | Option exercise | Common Stock | 15,602 | $8.72 | $136K | |
| Christine Ring - Officer | Open-market sale | Common Stock | 28,935 | $20.06 footnote F2 | $581K | |
| Christine Ring - Officer | Option exercise | Employee Stock Option (right to buy) | 13,333 | $0.00 | - | |
| Christine Ring - Officer | Option exercise | Employee Stock Option (right to buy) | 15,602 | $0.00 | - | |
| ||||||
| Christine Ring - Officer | Option exercise | Common Stock | 3,422 | $1.86 | $6K | |
| Christine Ring - Officer | Open-market sale | Common Stock | 8,148 | $16.60 footnote F2 | $135K | |
| Christine Ring - Officer | Option exercise | Employee Stock Option (right to buy) | 3,422 | $0.00 | - | |
| ||||||
| Paul M. Silva - Director | Grant or award | Director Stock Option (right to buy) | 31,250 | $0.00 | - | |
| Edward C. Saltzman - Director | Grant or award | Director Stock Option (right to buy) | 31,250 | $0.00 | - | |
 Judith A. Reinsdorf - Director | Grant or award | Director Stock Option (right to buy) | 31,250 | $0.00 | - | |
| David L. Lacey - Director | Grant or award | Director Stock Option (right to buy) | 31,250 | $0.00 | - | |
| Anil Kapur - Director | Grant or award | Director Stock Option (right to buy) | 31,250 | $0.00 | - | |
| Roger D. Dansey - Director | Grant or award | Director Stock Option (right to buy) | 31,250 | $0.00 | - | |
| Roy D. Baynes - Director | Grant or award | Director Stock Option (right to buy) | 31,250 | $0.00 | - | |
| Julia P. Gregory - Director | Grant or award | Director Stock Option (right to buy) | 31,250 | $0.00 | - | |
| Houte Hans van - Officer | Open-market sale | Common Stock | 13,473 | $16.58 footnote F2 | $223K | |
| Houte Hans van - Officer | Open-market sale | Common Stock | 582 | $17.18 footnote F3 | $10K | |
| ||||||
| Christine Ring - Officer | Open-market sale | Common Stock | 8,148 | $16.96 footnote F2 | $138K | |
| ||||||
| Christine Ring - Officer | Open-market sale | Common Stock | 5,394 | $16.76 footnote F2 | $90K | |
| ||||||
| Houte Hans van - Officer | Option exercise | Common Stock | 2,000 | $0.00 | - | |
| Houte Hans van - Officer | Option exercise | Common Stock | 3,750 | $0.00 | - | |
| Houte Hans van - Officer | Option exercise | Common Stock | 2,858 | $0.00 | - | |
| Houte Hans van - Officer | Open-market sale | Common Stock | 2,388 | $16.65 footnote F2 | $40K | |
| Houte Hans van - Officer | Option exercise | Restricted Stock Units | 2,000 | $0.00 | - | |
| Houte Hans van - Officer | Option exercise | Restricted Stock Units | 3,750 | $0.00 | - | |
| Houte Hans van - Officer | Option exercise | Restricted Stock Units | 2,858 | $0.00 | - | |
| ||||||
| Christine Ring - Officer | Option exercise | Common Stock | 2,000 | $0.00 | - | |
| Christine Ring - Officer | Option exercise | Common Stock | 3,750 | $0.00 | - | |
| Christine Ring - Officer | Option exercise | Common Stock | 2,858 | $0.00 | - | |
| Christine Ring - Officer | Open-market sale | Common Stock | 3,214 | $16.65 footnote F2 | $53K | |
| Christine Ring - Officer | Option exercise | Restricted Stock Units | 2,000 | $0.00 | - | |
| Christine Ring - Officer | Option exercise | Restricted Stock Units | 3,750 | $0.00 | - | |
| Christine Ring - Officer | Option exercise | Restricted Stock Units | 2,858 | $0.00 | - | |
| ||||||
| Gwenn Hansen - Officer | Open-market sale | Common Stock | 3,214 | $16.65 footnote F2 | $53K | |
| Gwenn Hansen - Officer | Option exercise | Common Stock | 2,000 | $0.00 | - | |
| Gwenn Hansen - Officer | Option exercise | Common Stock | 3,750 | $0.00 | - | |
| Gwenn Hansen - Officer | Option exercise | Common Stock | 2,858 | $0.00 | - | |
| Gwenn Hansen - Officer | Option exercise | Restricted Stock Units | 2,000 | $0.00 | - | |
| Gwenn Hansen - Officer | Option exercise | Restricted Stock Units | 3,750 | $0.00 | - | |
| Gwenn Hansen - Officer | Option exercise | Restricted Stock Units | 2,858 | $0.00 | - | |
| ||||||
| Christine Ring - Officer | Open-market sale | Common Stock | 8,148 | $15.24 footnote F2 | $124K | |
| ||||||
| Christine Ring - Officer | Open-market sale | Common Stock | 8,148 | $15.44 footnote F2 | $126K | |
| ||||||
| Houte Hans van - Officer | Grant or award | Employee Stock Option (right to buy) | 93,750 | $0.00 | - | |
| Houte Hans van - Officer | Grant or award | Restricted Stock Units | 42,875 | $0.00 | - | |
Item 2.02, 9.01
Item 2.02, 9.01
Item 7.01, 8.01, 9.01
Item 1.01, 7.01, 9.01
Recent NRIX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| CHRISTINE RING | Officer | 5,786 | $135K | View on EDGAR | |
| CHRISTINE RING | Officer | 5,787 |
NRIX insider trading FAQ
What is the latest insider trade for NRIX?
Nurix Therapeutics, Inc. (NRIX) had 9 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for NRIX runs to 62 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NRIX stock?
No insider purchases of NRIX were filed in the last 90 days.
How many insiders are selling NRIX stock?
12 insider sales of NRIX were filed in the last 90 days, totaling $1.17M.
Where can I see NRIX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NRIX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Christine Ring view on EDGAR
- - Christine Ring view on EDGAR
- - Gwenn Hansen view on EDGAR
- - Gwenn Hansen view on EDGAR
- - Houte Hans van view on EDGAR
- - Christine Ring view on EDGAR
- - Houte Hans van view on EDGAR
- - Christine Ring view on EDGAR
- - Gwenn Hansen view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where NRIX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NRIX with a 7-day demo
- NRIX on your watchlist
- Every NRIX Form 4 filing on record
- Up to 3 months of NRIX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
